ATRC
AtriCure Inc
NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$28.11
+2.82% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.59x
EPS (TTM)
$-0.24
Dividend yield
—
52W range
$27 – $43
Volume
0.7M
AtriCure Inc (ATRC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-2.14%
Operating margin
1.77%
ROE
-2.40%
ROA
-0.94%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $38.24M | $-13.72M | 80.06% | -38.62% | -35.87% |
| 2007 | $48.31M | $-11.25M | 79.02% | -26.02% | -23.29% |
| 2008 | $55.26M | $-10.17M | 76.07% | -19.90% | -18.40% |
| 2009 | $54.53M | $-16.49M | 76.62% | -28.44% | -30.25% |
| 2010 | $59.01M | $-3.79M | 76.92% | -5.41% | -6.43% |
| 2011 | $64.40M | $-5.46M | 72.97% | -7.35% | -8.47% |
| 2012 | $70.25M | $-7.53M | 71.20% | -10.25% | -10.73% |
| 2013 | $81.89M | $-11.46M | 72.74% | -13.30% | -14.00% |
| 2014 | $107.45M | $-16.21M | 70.50% | -15.23% | -15.09% |
| 2015 | $129.75M | $-27.21M | 71.58% | -20.59% | -20.97% |
| 2016 | $155.11M | $-33.34M | 71.63% | -20.07% | -21.49% |
| 2017 | $174.72M | $-26.89M | 72.21% | -14.30% | -15.39% |
| 2018 | $201.63M | $-21.14M | 72.97% | -8.49% | -10.48% |
| 2019 | $230.81M | $-35.19M | 73.80% | -14.35% | -15.25% |
| 2020 | $206.53M | $-48.16M | 72.29% | -21.42% | -23.32% |
| 2021 | $274.33M | $50.20M | 75.04% | 20.12% | 18.30% |
| 2022 | $330.38M | $-46.47M | 74.44% | -12.92% | -14.06% |
| 2023 | $399.25M | $-30.44M | 75.23% | -6.68% | -7.62% |
| 2024 | $465.31M | $-44.70M | 74.69% | -8.60% | -9.61% |
| 2025 | $534.53M | $-11.45M | 74.41% | -0.64% | -2.14% |